25 Mar, 2024 A detailed analysis of the first substantive UPC Court of Appeal decision – lifting a preliminary injunction against NanoString By Eden Winlow NanoString Technologies Inc.; NanoString Technologies Germany GmbH; NanoString Technologies Netherlands B.V. v President and Fellows of...
01 Mar, 2024 MHRA grants first medicine approval via the new International Recognition Procedure By Jamie Hatzel For the very first time, the MHRA has a granted a UK marketing authorisation (UKMA) for a medicine through its new International...
21 Feb, 2024 Will it be possible to lawfully test an AI Medical Device? By Alex Denoon A brief analysis of the interaction between the proposed AI Act and the MDR The AI Act continues to contain a concerning flaw as regards...
12 Feb, 2024 UPC case numbers, statistics and technologies update By Eden Winlow The UPC has published an update on the caseload of the Court since its start of operation in June 2023. The number of cases has continued...
29 Jan, 2024 Implementation deadlines for the EU In Vitro Diagnostic Medical Device Regulation further postponed By Alex Denoon Melissa Dix Extending the transitional periods for implementation A considerable number of in vitro diagnostic medical devices (IVDs) currently on...
23 Jan, 2024 UK MDR: further delays, unexpected developments? - Bristows By Alex Denoon Jamie Hatzel On 9 January 2024, the MHRA published a new Regulatory Roadmap, which sets out the expected timeline and key milestones on the way to the...
18 Jan, 2024 Publication: Biotech Review of the Year By Gregory Bacon Xisca Borrás Will Hewitt 2023 is likely to be remembered as a year in which a number of highly anticipated developments in the biotech industry finally came to...
10 Jan, 2024 Podcast: In conversation with AstraZeneca By Vik Khurana In this episode of our digital transformation podcast - The Roadmap - I was joined by two very special guests, Adam McArthur and Warren...
15 Dec, 2023 Genesis 2023: The UK life sciences ecosystem under the microscope By Claire Smith Harry Woodcock Last week, Claire Smith and Harry Woodcock from Bristows’ life sciences transactional team attended Genesis 2023, an annual conference...
13 Nov, 2023 Failing faster using AI cannot be considered a success – A round-up of TechBio UK 2023 conference By Claire Smith Gemma Gibbs Will Hewitt Will Hewitt, Gemma Gibbs and Claire Smith provide key takeaways from TechBio UK 2023
09 Nov, 2023 Human embryo research: should we re-draw the line? By Melissa Dix Melissa Dix discusses the 14-day rule for embryonic research implemented by the Human Fertilisation and Embryology Act 1990 and asks...
02 Nov, 2023 Tech M&A podcast: First two episodes now available By Julia Cockroft Chris Devlin Jamie Hatzel Sophie Rees +1 more... Show less In line with the UK’s bid to become a global leader in innovation, we are seeing an increased focus on deals driven by pioneering...